Assembly Biosciences Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 02/12/2026 | 4.51 M | $153.23 M | 0.00% | 58.85% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.23 M | $41.75 M | 0.00% | 16.03% |
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 1.02 M | $34.70 M | 0.00% | 13.33% |
| COMMODORE CAPITAL LP | 02/17/2026 | 1.00 M | $34.01 M | 0.00% | 13.06% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 837.93 K | $28.54 M | 11.33% | 10.94% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/17/2026 | 665.25 K | $22.63 M | 100.00% | 8.69% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 600.61 K | $20.43 M | 102.90% | 7.85% |
| VANGUARD GROUP INC | 01/29/2026 | 572.90 K | $19.48 M | 14.10% | 7.48% |
| BLACKSTONE INC. | 02/17/2026 | 318.75 K | $10.84 M | -28.82% | 4.16% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 249.36 K | $8.48 M | -0.65% | 3.26% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 210.53 K | $7.16 M | -11.61% | 2.75% |
| BLACKROCK, INC. | 02/12/2026 | 192.30 K | $6.54 M | 12.98% | 2.51% |
| B GROUP, INC. | 02/17/2026 | 175.71 K | $5.98 M | 0.00% | 2.30% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 161.00 K | $5.48 M | 100.00% | 2.10% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 159.68 K | $5.43 M | 100.00% | 2.09% |
| STEMPOINT CAPITAL LP | 02/17/2026 | 156.73 K | $5.33 M | 137.00% | 2.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 131.31 K | $4.47 M | 0.93% | 1.72% |
| MARSHALL WACE, LLP | 02/13/2026 | 129.08 K | $4.39 M | 51.47% | 1.69% |
| PATIENT SQUARE CAPITAL LP | 02/12/2026 | 127.00 K | $4.32 M | -6.05% | 1.66% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 106.59 K | $3.63 M | 100.00% | 1.39% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 98.22 K | $3.34 M | 354.56% | 1.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 80.39 K | $2.73 M | -38.64% | 1.05% |
| 04/02/2026 | 73.76 K | $2.51 M | 100.00% | 0.96% | |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/17/2026 | 65.27 K | $2.22 M | 100.00% | 0.85% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 54.24 K | $1.84 M | -55.50% | 0.71% |
| JANE STREET GROUP, LLC | 02/12/2026 | 53.70 K | $1.83 M | 58.75% | 0.70% |
| STATE STREET CORP | 02/13/2026 | 52.99 K | $1.80 M | 18.24% | 0.69% |
| JPMORGAN CHASE & CO | 02/11/2026 | 48.16 K | $1.64 M | 687,885.71% | 0.63% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 42.19 K | $1.43 M | 282.46% | 0.55% |
| NORTHERN TRUST CORP | 02/17/2026 | 41.23 K | $1.40 M | 3.18% | 0.54% |
| MONIMUS CAPITAL MANAGEMENT, LP | 02/17/2026 | 38.30 K | $1.30 M | -8.95% | 0.50% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 37.81 K | $1.29 M | 100.00% | 0.49% |
| PALUMBO WEALTH MANAGEMENT LLC | 01/21/2026 | 37.31 K | $1.27 M | 7.20% | 0.49% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 34.79 K | $1.18 M | 97.07% | 0.45% |
| CITADEL ADVISORS LLC | 02/17/2026 | 32.87 K | $1.12 M | -39.00% | 0.43% |
| ELLSWORTH ADVISORS, LLC | 01/16/2026 | 29.74 K | $889.37 K | -0.72% | 0.39% |
| EAM INVESTORS, LLC | 02/12/2026 | 29.52 K | $1.00 M | 1.55% | 0.39% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 28.28 K | $961.67 K | 125.74% | 0.37% |
| 683 CAPITAL MANAGEMENT, LLC | 02/17/2026 | 27.86 K | $947.62 K | 100.00% | 0.36% |
| FEDERATED HERMES, INC. | 02/12/2026 | 25.39 K | $863.65 K | 0.00% | 0.33% |
| BARCLAYS PLC | 02/13/2026 | 24.74 K | $841.44 K | 524.62% | 0.32% |
| MORGAN STANLEY | 02/13/2026 | 22.53 K | $766.38 K | 538.90% | 0.29% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 20.80 K | $707.48 K | 86.46% | 0.27% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 19.75 K | $671.60 K | 4.22% | 0.26% |
| SEI INVESTMENTS CO | 02/13/2026 | 17.75 K | $603.51 K | 100.00% | 0.23% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 15.60 K | $530.49 K | 100.00% | 0.20% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 15.05 K | $511.85 K | 100.00% | 0.20% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 02/17/2026 | 13.90 K | $472.84 K | 100.00% | 0.18% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 13.08 K | $444.92 K | 100.00% | 0.17% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 12.70 K | $432.00 K | 2.25% | 0.17% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Assembly Biosciences Inc institutional Ownership - FAQ's
During the previous two years, 96 institutional investors and hedge funds held shares of Assembly Biosciences Inc. The most heavily invested institutionals were:
GILEAD SCIENCES, INC.: 4.51 M
VANGUARD FIDUCIARY TRUST CO: 71,606
GSA CAPITAL PARTNERS LLP: 45,049
JANE STREET GROUP, LLC: 34,499
Connor, Clark & Lunn Investment Management Ltd.: 21,761
Palumbo Wealth Management LLC: 19,643
179.26% of Assembly Biosciences Inc stock is owned by institutional investors.
Institutional investors have bought a total of 14.36 M shares in the last 24 months. This purchase volume represents approximately $418.19 M in transactions.